Abstract
Several studies have reported that the variability in pharmacokinetic (PK) parameters after intravenous busulfan dosing is significantly lower than that recorded after dosing with the oral formulation. However, other published experiences have concluded that both the oral and intravenous formulation of busulfan yield wide interpatient variability in PK parameters.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
